Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Bertolini

Showing results (151-160 of 169) with videos related to

Pageof 17
Sort By:
Leukemia|July 25, 2021
Dual targeting of the DNA damage response pathway and BCL-2 in diffuse large B-cell lymphomaAlessandra Rossi, Stefania Orecchioni, Paolo Falvo, et al.
Plos One|August 12, 2010
EPO receptor gain-of-function causes hereditary polycythemia, alters CD34 cell differentiation and increases circulating endothelial precursorsSilverio Perrotta, Valeria Cucciolla, Marcella Ferraro, et al.
Haematologica|October 14, 2017
Depletion of SIRT6 enzymatic activity increases acute myeloid leukemia cells' vulnerability to DNA-damaging agentsAntonia Cagnetta, Debora Soncini, Stefania Orecchioni, et al.
Scientific Reports|May 11, 2018
Mitochondrial Complex I activity signals antioxidant response through ERK5Abrar Ul Haq Khan, Nerea Allende-Vega, Delphine Gitenay, et al.
Scientific Reports|September 8, 2017
The PDK1 Inhibitor Dichloroacetate Controls Cholesterol Homeostasis Through the ERK5/MEF2 PathwayAbrar Ul Haq Khan, Nerea Allende-Vega, Delphine Gitenay, et al.
Cancer Prevention Research (Philadelphia, Pa.)|November 13, 2023
High-Fat Diet Promotes Acute Promyelocytic Leukemia through PPARδ-Enhanced Self-renewal of Preleukemic ProgenitorsLuca Mazzarella, Paolo Falvo, Marta Adinolfi, et al.
Haematologica|October 15, 2020
The new small tyrosine kinase inhibitor ARQ531 targets acute myeloid leukemia cells by disrupting multiple tumor-addicted programsDebora Soncini, Stefania Orecchioni, Samantha Ruberti, et al.
Ecancermedicalscience|December 21, 2016
Next generation metronomic chemotherapy-report from the Fifth Biennial International Metronomic and Anti-angiogenic Therapy Meeting, 6-8 May 2016, MumbaiPan Pantziarka, Lisa Hutchinson, Nicolas André, et al.
Ecancermedicalscience|September 18, 2014
Lessons from the Fourth Metronomic and Anti-angiogenic Therapy Meeting, 24-25 June 2014, MilanGauthier Bouche, Nicolas André, Shripad Banavali, et al.
Therapeutic Advances in Medical Oncology|June 17, 2024
Circulating tumor DNA in patients with locally advanced rectal cancer treated with multimodal treatmentLorenzo Gervaso, Davide Ciardiello, Giuliana Gregato, et al.
Pageof 17

Showing results (151-160 of 169) with videos related to

Sort By:
Pageof 17
Leukemia|July 25, 2021
Dual targeting of the DNA damage response pathway and BCL-2 in diffuse large B-cell lymphomaAlessandra Rossi, Stefania Orecchioni, Paolo Falvo, et al.
Plos One|August 12, 2010
EPO receptor gain-of-function causes hereditary polycythemia, alters CD34 cell differentiation and increases circulating endothelial precursorsSilverio Perrotta, Valeria Cucciolla, Marcella Ferraro, et al.
Haematologica|October 14, 2017
Depletion of SIRT6 enzymatic activity increases acute myeloid leukemia cells' vulnerability to DNA-damaging agentsAntonia Cagnetta, Debora Soncini, Stefania Orecchioni, et al.
Scientific Reports|May 11, 2018
Mitochondrial Complex I activity signals antioxidant response through ERK5Abrar Ul Haq Khan, Nerea Allende-Vega, Delphine Gitenay, et al.
Scientific Reports|September 8, 2017
The PDK1 Inhibitor Dichloroacetate Controls Cholesterol Homeostasis Through the ERK5/MEF2 PathwayAbrar Ul Haq Khan, Nerea Allende-Vega, Delphine Gitenay, et al.
Cancer Prevention Research (Philadelphia, Pa.)|November 13, 2023
High-Fat Diet Promotes Acute Promyelocytic Leukemia through PPARδ-Enhanced Self-renewal of Preleukemic ProgenitorsLuca Mazzarella, Paolo Falvo, Marta Adinolfi, et al.
Haematologica|October 15, 2020
The new small tyrosine kinase inhibitor ARQ531 targets acute myeloid leukemia cells by disrupting multiple tumor-addicted programsDebora Soncini, Stefania Orecchioni, Samantha Ruberti, et al.
Ecancermedicalscience|December 21, 2016
Next generation metronomic chemotherapy-report from the Fifth Biennial International Metronomic and Anti-angiogenic Therapy Meeting, 6-8 May 2016, MumbaiPan Pantziarka, Lisa Hutchinson, Nicolas André, et al.
Ecancermedicalscience|September 18, 2014
Lessons from the Fourth Metronomic and Anti-angiogenic Therapy Meeting, 24-25 June 2014, MilanGauthier Bouche, Nicolas André, Shripad Banavali, et al.
Therapeutic Advances in Medical Oncology|June 17, 2024
Circulating tumor DNA in patients with locally advanced rectal cancer treated with multimodal treatmentLorenzo Gervaso, Davide Ciardiello, Giuliana Gregato, et al.
Pageof 17